Indicator type	Execution Sectors	Total
Units carrying out R&D in Biotechnology	Total	1.636
Units carrying out R&D in Biotechnology	Companies	113
Units carrying out R&D in Biotechnology	Public Administration	68
Units carrying out R&D in Biotechnology	Higher Education	1.444
Units carrying out R&D in Biotechnology	NPPI	11
% Units by type of biotechnology used: Genetic Code	Total	37,2
% Units by type of biotechnology used: Genetic Code	Companies	87,6
% Units by type of biotechnology used: Genetic Code	Public Administration	94,1
% Units by type of biotechnology used: Genetic Code	Higher Education	30,7
% Units by type of biotechnology used: Genetic Code	NPPI	27,3
% Units by type of biotechnology used: Functional Units	Total	43,5
% Units by type of biotechnology used: Functional Units	Companies	86,7
% Units by type of biotechnology used: Functional Units	Public Administration	95,6
% Units by type of biotechnology used: Functional Units	Higher Education	37,6
% Units by type of biotechnology used: Functional Units	NPPI	54,5
% Units by type of biotechnology used: Cell and Tissue Culture and Engineering	Total	27,6
% Units by type of biotechnology used: Cell and Tissue Culture and Engineering	Companies	72,6
% Units by type of biotechnology used: Cell and Tissue Culture and Engineering	Public Administration	80,9
% Units by type of biotechnology used: Cell and Tissue Culture and Engineering	Higher Education	21,3
% Units by type of biotechnology used: Cell and Tissue Culture and Engineering	NPPI	63,6
% Units by type of biotechnology used: Bioprocesses	Total	53,6
% Units by type of biotechnology used: Bioprocesses	Companies	65,5
% Units by type of biotechnology used: Bioprocesses	Public Administration	91,2
% Units by type of biotechnology used: Bioprocesses	Higher Education	50,9
% Units by type of biotechnology used: Bioprocesses	NPPI	54,5
% Units by type of biotechnology used: Subcellular Organisms	Total	13,9
% Units by type of biotechnology used: Subcellular Organisms	Companies	55,8
% Units by type of biotechnology used: Subcellular Organisms	Public Administration	64,7
% Units by type of biotechnology used: Subcellular Organisms	Higher Education	8,1
% Units by type of biotechnology used: Subcellular Organisms	NPPI	36,4
% Units by type of biotechnology used: Bioinformatics	Total	28,7
% Units by type of biotechnology used: Bioinformatics	Companies	71,7
% Units by type of biotechnology used: Bioinformatics	Public Administration	83,8
% Units by type of biotechnology used: Bioinformatics	Higher Education	22,6
% Units by type of biotechnology used: Bioinformatics	NPPI	36,4
% Units by type of biotechnology used: Nanobiotechnology	Total	15,5
% Units by type of biotechnology used: Nanobiotechnology	Companies	53,1
% Units by type of biotechnology used: Nanobiotechnology	Public Administration	73,5
% Units by type of biotechnology used: Nanobiotechnology	Higher Education	9,8
% Units by type of biotechnology used: Nanobiotechnology	NPPI	18,2
% Units by type of biotechnology used: Other	Total	15,7
% Units by type of biotechnology used: Other	Companies	7,1
% Units by type of biotechnology used: Other	Public Administration	7,3
% Units by type of biotechnology used: Other	Higher Education	16,9
% Units by type of biotechnology used: Other	NPPI	9,1
Units in which biotechnology activities are: Main and/or exclusive	Total	676
Units in which biotechnology activities are: Main and/or exclusive	Companies	35
Units in which biotechnology activities are: Main and/or exclusive	Public Administration	5
Units in which biotechnology activities are: Main and/or exclusive	Higher Education	629
Units in which biotechnology activities are: Main and/or exclusive	NPPI	7
Units in which biotechnology activities are: A secondary business line	Total	347
Units in which biotechnology activities are: A secondary business line	Companies	36
Units in which biotechnology activities are: A secondary business line	Public Administration	47
Units in which biotechnology activities are: A secondary business line	Higher Education	262
Units in which biotechnology activities are: A secondary business line	NPPI	2
Units in which biotechnology activities are: A necessary tool for production	Total	613
Units in which biotechnology activities are: A necessary tool for production	Companies	42
Units in which biotechnology activities are: A necessary tool for production	Public Administration	16
Units in which biotechnology activities are: A necessary tool for production	Higher Education	553
Units in which biotechnology activities are: A necessary tool for production	NPPI	2
% Units by final application areas of biotechnology use: Human Health	Total	48,7
% Units by final application areas of biotechnology use: Human Health	Companies	76,1
% Units by final application areas of biotechnology use: Human Health	Public Administration	92,7
% Units by final application areas of biotechnology use: Human Health	Higher Education	44,3
% Units by final application areas of biotechnology use: Human Health	NPPI	72,7
% Units by final application areas of biotechnology use: Animal Health and Aquaculture	Total	17,8
% Units by final application areas of biotechnology use: Animal Health and Aquaculture	Companies	18,6
% Units by final application areas of biotechnology use: Animal Health and Aquaculture	Public Administration	61,8
% Units by final application areas of biotechnology use: Animal Health and Aquaculture	Higher Education	15,8
% Units by final application areas of biotechnology use: Animal Health and Aquaculture	NPPI	9,1
% Units by final application areas of biotechnology use: Food Products	Total	32,4
% Units by final application areas of biotechnology use: Food Products	Companies	26,6
% Units by final application areas of biotechnology use: Food Products	Public Administration	82,3
% Units by final application areas of biotechnology use: Food Products	Higher Education	30,7
% Units by final application areas of biotechnology use: Food Products	NPPI	0
% Units by final application areas of biotechnology use: Agriculture and Forestry	Total	26,4
% Units by final application areas of biotechnology use: Agriculture and Forestry	Companies	21,2
% Units by final application areas of biotechnology use: Agriculture and Forestry	Public Administration	67,7
% Units by final application areas of biotechnology use: Agriculture and Forestry	Higher Education	24,9
% Units by final application areas of biotechnology use: Agriculture and Forestry	NPPI	18,2
% Units by final application areas of biotechnology use: Environment	Total	19,8
% Units by final application areas of biotechnology use: Environment	Companies	23,9
% Units by final application areas of biotechnology use: Environment	Public Administration	75
% Units by final application areas of biotechnology use: Environment	Higher Education	16,9
% Units by final application areas of biotechnology use: Environment	NPPI	9,1
% Units by final application areas of biotechnology use: Industry	Total	15,2
% Units by final application areas of biotechnology use: Industry	Companies	18,6
% Units by final application areas of biotechnology use: Industry	Public Administration	66,2
% Units by final application areas of biotechnology use: Industry	Higher Education	12,6
% Units by final application areas of biotechnology use: Industry	NPPI	9,1
R&D personnel in Biotechnology (PP)	Total	50.084
R&D personnel in Biotechnology (PP)	Companies	15.563
R&D personnel in Biotechnology (PP)	Public Administration	16.597
R&D personnel in Biotechnology (PP)	Higher Education	17.743
R&D personnel in Biotechnology (PP)	NPPI	181
R&D personnel in Biotechnology (PP): Research personnel	Total	32.396
R&D personnel in Biotechnology (PP): Research personnel	Companies	9.798
R&D personnel in Biotechnology (PP): Research personnel	Public Administration	13.026
R&D personnel in Biotechnology (PP): Research personnel	Higher Education	9.445
R&D personnel in Biotechnology (PP): Research personnel	NPPI	127
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel	Total	17.688
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel	Companies	5.765
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel	Public Administration	3.571
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel	Higher Education	8.298
R&D personnel in Biotechnology (PP): Technical and auxiliary personnel	NPPI	54
R&D personnel in Biotechnology (PP). Women	Total	28.401
R&D personnel in Biotechnology (PP). Women	Companies	9.804
R&D personnel in Biotechnology (PP). Women	Public Administration	8.578
R&D personnel in Biotechnology (PP). Women	Higher Education	9.907
R&D personnel in Biotechnology (PP). Women	NPPI	112
R&D personnel in Biotechnology (PP). Women: Research personnel	Total	17.461
R&D personnel in Biotechnology (PP). Women: Research personnel	Companies	5.851
R&D personnel in Biotechnology (PP). Women: Research personnel	Public Administration	6.435
R&D personnel in Biotechnology (PP). Women: Research personnel	Higher Education	5.104
R&D personnel in Biotechnology (PP). Women: Research personnel	NPPI	71
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel	Total	10.939
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel	Companies	3.953
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel	Public Administration	2.143
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel	Higher Education	4.802
R&D personnel in Biotechnology (PP). Women: Technical and auxiliary personnel	NPPI	41
R&D personnel in Biotechnology (FTE)	Total	35.301,2
R&D personnel in Biotechnology (FTE)	Companies	11.442,1
R&D personnel in Biotechnology (FTE)	Public Administration	10.721,9
R&D personnel in Biotechnology (FTE)	Higher Education	12.993,4
R&D personnel in Biotechnology (FTE)	NPPI	143,8
R&D personnel in Biotechnology (FTE): Research personnel	Total	22.324,6
R&D personnel in Biotechnology (FTE): Research personnel	Companies	6.766,8
R&D personnel in Biotechnology (FTE): Research personnel	Public Administration	8.386,7
R&D personnel in Biotechnology (FTE): Research personnel	Higher Education	7.069,9
R&D personnel in Biotechnology (FTE): Research personnel	NPPI	101,2
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel	Total	12.976,7
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel	Companies	4.675,3
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel	Public Administration	2.335,2
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel	Higher Education	5.923,6
R&D personnel in Biotechnology (FTE): Technical and auxiliary personnel	NPPI	42,6
R&D personnel in Biotechnology (FTE). Women	Total	20.474,8
R&D personnel in Biotechnology (FTE). Women	Companies	7.280,8
R&D personnel in Biotechnology (FTE). Women	Public Administration	5.633,9
R&D personnel in Biotechnology (FTE). Women	Higher Education	7.471,8
R&D personnel in Biotechnology (FTE). Women	NPPI	88,3
R&D personnel in Biotechnology (FTE). Women: Research personnel	Total	12.176,5
R&D personnel in Biotechnology (FTE). Women: Research personnel	Companies	4.080,5
R&D personnel in Biotechnology (FTE). Women: Research personnel	Public Administration	4.171,9
R&D personnel in Biotechnology (FTE). Women: Research personnel	Higher Education	3.870,1
R&D personnel in Biotechnology (FTE). Women: Research personnel	NPPI	54
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel	Total	8.298,2
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel	Companies	3.200,3
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel	Public Administration	1.462
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel	Higher Education	3.601,6
R&D personnel in Biotechnology (FTE). Women: Technical and auxiliary personnel	NPPI	34,3
Expenditure on internal R&D in Biotechnology (thousands of euros)	Total	2.565.367
Expenditure on internal R&D in Biotechnology (thousands of euros)	Companies	775.164
Expenditure on internal R&D in Biotechnology (thousands of euros)	Public Administration	554.906
Expenditure on internal R&D in Biotechnology (thousands of euros)	Higher Education	1.223.801
Expenditure on internal R&D in Biotechnology (thousands of euros)	NPPI	11.496
1) By type of expenditure: Current expenditure	Total	2.359.528
1) By type of expenditure: Current expenditure	Companies	727.099
1) By type of expenditure: Current expenditure	Public Administration	513.043
1) By type of expenditure: Current expenditure	Higher Education	1.108.189
1) By type of expenditure: Current expenditure	NPPI	11.197
1.1) Labour expenditure of research personnel	Total	950.162
1.1) Labour expenditure of research personnel	Companies	267.235
1.1) Labour expenditure of research personnel	Public Administration	318.977
1.1) Labour expenditure of research personnel	Higher Education	360.922
1.1) Labour expenditure of research personnel	NPPI	3.027
1.2) Labour expenditure of technical and auxiliary personnel	Total	421.784
1.2) Labour expenditure of technical and auxiliary personnel	Companies	128.800
1.2) Labour expenditure of technical and auxiliary personnel	Public Administration	71.268
1.2) Labour expenditure of technical and auxiliary personnel	Higher Education	220.540
1.2) Labour expenditure of technical and auxiliary personnel	NPPI	1.176
1.3) Other current expenditure	Total	987.583
1.3) Other current expenditure	Companies	331.063
1.3) Other current expenditure	Public Administration	122.798
1.3) Other current expenditure	Higher Education	526.727
1.3) Other current expenditure	NPPI	6.994
2) By type of expenditure: Capital expenditure	Total	205.839
2) By type of expenditure: Capital expenditure	Companies	48.066
2) By type of expenditure: Capital expenditure	Public Administration	41.862
2) By type of expenditure: Capital expenditure	Higher Education	115.612
2) By type of expenditure: Capital expenditure	NPPI	299
2.1) Land and buildings	Total	30.577
2.1) Land and buildings	Companies	6.521
2.1) Land and buildings	Public Administration	7.162
2.1) Land and buildings	Higher Education	16.843
2.1) Land and buildings	NPPI	52
2.2) Equipment and tools	Total	136.544
2.2) Equipment and tools	Companies	39.416
2.2) Equipment and tools	Public Administration	33.362
2.2) Equipment and tools	Higher Education	63.527
2.2) Equipment and tools	NPPI	239
2.3) Acquisition of specific R&D software	Total	7.117
2.3) Acquisition of specific R&D software	Companies	1.945
2.3) Acquisition of specific R&D software	Public Administration	1.211
2.3) Acquisition of specific R&D software	Higher Education	3.959
2.3) Acquisition of specific R&D software	NPPI	3
2.4) Other R&D-specific IP products	Total	31.601
2.4) Other R&D-specific IP products	Companies	184
2.4) Other R&D-specific IP products	Public Administration	128
2.4) Other R&D-specific IP products	Higher Education	31.284
2.4) Other R&D-specific IP products	NPPI	5
1.1) By origin of funds: Own funds	Total	1.030.214
1.1) By origin of funds: Own funds	Companies	78.546
1.1) By origin of funds: Own funds	Public Administration	90.048
1.1) By origin of funds: Own funds	Higher Education	860.603
1.1) By origin of funds: Own funds	NPPI	1.016
1.2) By origin of funds: Funds from the Business sector	Total	277.770
1.2) By origin of funds: Funds from the Business sector	Companies	115.144
1.2) By origin of funds: Funds from the Business sector	Public Administration	27.808
1.2) By origin of funds: Funds from the Business sector	Higher Education	128.002
1.2) By origin of funds: Funds from the Business sector	NPPI	6.816
1.3) By origin of funds: Funds from the Public Administration sector	Total	951.439
1.3) By origin of funds: Funds from the Public Administration sector	Companies	458.700
1.3) By origin of funds: Funds from the Public Administration sector	Public Administration	372.119
1.3) By origin of funds: Funds from the Public Administration sector	Higher Education	119.498
1.3) By origin of funds: Funds from the Public Administration sector	NPPI	1.122
1.4) By origin of funds: Funds from the Higher Education sector	Total	4.307
1.4) By origin of funds: Funds from the Higher Education sector	Companies	1.537
1.4) By origin of funds: Funds from the Higher Education sector	Public Administration	2.122
1.4) By origin of funds: Funds from the Higher Education sector	Higher Education	647
1.4) By origin of funds: Funds from the Higher Education sector	NPPI	0
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector	Total	52.107
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector	Companies	28.686
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector	Public Administration	9.445
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector	Higher Education	12.986
1.5) By origin of funds: Funds from the Private Non-Profit Institutions sector	NPPI	990
1.6) By origin of funds: Funds from the rest of the world	Total	249.530
1.6) By origin of funds: Funds from the rest of the world	Companies	92.551
1.6) By origin of funds: Funds from the rest of the world	Public Administration	53.363
1.6) By origin of funds: Funds from the rest of the world	Higher Education	102.065
1.6) By origin of funds: Funds from the rest of the world	NPPI	1.551
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros)	Total	171.660
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros)	Companies	35.006
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros)	Public Administration	13.038
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros)	Higher Education	123.396
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros)	NPPI	220
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain	Total	131.863
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain	Companies	30.282
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain	Public Administration	12.385
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain	Higher Education	88.985
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In Spain	NPPI	212
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world	Total	39.797
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world	Companies	4.725
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world	Public Administration	653
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world	Higher Education	34.412
Purchase of R&D services (external R&D) in Biotechnology (thousands of euros): In the rest of the world	NPPI	8
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to capital	Total	41,8
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to capital	Companies	57,5
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to capital	Public Administration	52,9
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to capital	Higher Education	39,8
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to capital	NPPI	72,7
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information	Total	14,8
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information	Companies	8,8
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information	Public Administration	14,7
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information	Higher Education	15,3
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to technology/information	NPPI	9,1
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to human resources	Total	24,5
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to human resources	Companies	46
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to human resources	Public Administration	36,8
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to human resources	Higher Education	22,3
% Units that consider the following obstacles to the development of biotechnologies as very important: Access to human resources	NPPI	18,2
% Units that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain	Total	13,8
% Units that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain	Companies	23
% Units that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain	Public Administration	35,3
% Units that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain	Higher Education	12,1
% Units that consider the following obstacles to the development of biotechnologies as very important: Disconnection from the value chain	NPPI	9,1
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets	Total	19
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets	Companies	28,3
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets	Public Administration	44,1
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets	Higher Education	17,1
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of access to international markets	NPPI	27,3
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels	Total	19,4
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels	Companies	28,3
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels	Public Administration	38,2
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels	Higher Education	17,8
% Units that consider the following obstacles to the development of biotechnologies as very important: Lack of distribution and marketing channels	NPPI	18,2
% Units that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception	Total	15,3
% Units that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception	Companies	10,6
% Units that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception	Public Administration	10,3
% Units that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception	Higher Education	16
% Units that consider the following obstacles to the development of biotechnologies as very important: Public acceptance/perception	NPPI	9,1
% Units that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements	Total	41,3
% Units that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements	Companies	40,7
% Units that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements	Public Administration	39,7
% Units that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements	Higher Education	41,4
% Units that consider the following obstacles to the development of biotechnologies as very important: Legal and regulatory requirements	NPPI	36,4
% Units that consider the following obstacles to the development of biotechnologies as very important: Time/cost	Total	51,2
% Units that consider the following obstacles to the development of biotechnologies as very important: Time/cost	Companies	62,8
% Units that consider the following obstacles to the development of biotechnologies as very important: Time/cost	Public Administration	51,5
% Units that consider the following obstacles to the development of biotechnologies as very important: Time/cost	Higher Education	50,2
% Units that consider the following obstacles to the development of biotechnologies as very important: Time/cost	NPPI	63,6
% Units that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting	Total	20
% Units that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting	Companies	19,5
% Units that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting	Public Administration	19,1
% Units that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting	Higher Education	20,1
% Units that consider the following obstacles to the development of biotechnologies as very important: Difficult access to patenting	NPPI	18,2